Donor lymphocyte infusion after allogeneic stem cell transplantation is a feasible therapy option with acceptable toxicity rates in patients with advanced Ewing sarcoma and rhabdomyosarcoma
ONCOLOGY RESEARCH AND TREATMENT(2018)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要